Just Seized Drugs and Toxicology Portfolio

Just Seized Drugs and Toxicology Portfolio

Original Release Date: June 4, 2021

In episode one of our 2021 NIJ R&D and Beyond mini season, Just Science sat down with Dr. Frances Scott, a physical scientist in the Office of Investigative and Forensic Sciences at the National Institute of Justice, to discuss the Seized Drugs and Toxicology research and development portfolio. 

With the introduction of new and more complex substances every year, forensic laboratories need access to the most cutting-edge technology to stay on the forefront of the Opioid Epidemic. Dr. Frances Scott oversees NIJ's Seized Drugs and Forensic Toxicology R&D portfolio in a concerted effort to provide the latest quality research to the public. Listen along as she discusses the addition of the research for publicly funded labs program, the complexity of toxicology analysis, and the NIJ’s research portfolio in the discipline of seized drugs in this episode of Just Science.

This episode of Just Science is funded by the National Institute of Justice’s Forensic Technology Center of Excellence [Award 2016-MU-BX-K110].

Listen to or download the episode here:

Apple Podcasts    Stitcher    Soundcloud    Spotify    Google Podcasts

View or download the episode transcript here:

Guest Biography

Frances Scott is a Physical Scientist at the National Institute of Justice, where she manages the Seized Drugs and Forensic Toxicology research and development portfolios under the General Forensics portfolio, as well as the Research for Publicly Funded Labs program.  Dr. Scott received a B.S. in chemistry from the University of California at Davis and a Ph.D. in physical chemistry from the George Washington University.

The opinions, findings, and conclusions or recommendations expressed in this podcast episode are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at with any questions and subscribe to our newsletter for notifications.

Related Content

LC-DAD with Optional ESI/MS: An Emerging Gold Standard for Hemp Compliance Testing

← Back to Webinar Series Page Thursday, June 13, 2024 | 1:00 PM – 2:00 PM Eastern Duration: 1 hour Overview Hemp compliance testing is used to quantify total Δ9-tetrahydrocannabinol (Δ9-THC), including both Δ9-THC and its precursor, i.e., Δ9-tetrahydrocannabinolic acid…